Idan Tamir

Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel.

Agazyme Ltd. operates was a biotech company. It was engages in the research and development of alkaline alpha galactosides for food, beverage, and cosmetic industries. The company was founded in 2007 and is headquartered in Tel Aviv, Israel.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

ImmunArray Ltd. develops novel in-vitro diagnostic tests. Its products support a personalized medicine approach and IAL's first product family will provide tests for diagnosis, prognosis and therapeutic guidance of autoimmune diseases and for improving transplantation medicine. The firm is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company was founded by Eli Sahar & Irun Cohen in 2006 and is headquartered in Rehovot, Israel.

National Jewish Health, Inc. provides healthcare services. It offers personalized medicines that prevents and treats respiratory, cardiac, immune and related disorders. The company was founded in 1899 and is headquartered in Denver, CO.

Xenolith Medical Ltd. develops and manufactures medical devices. Its product XenX involves a very thin mesh structure that is constructed as an integral part of a guide wire. The firm is also developing additional tools in the endourological niche. The company was founded by Shaul Shohat and Ido Kilemnik in 2010 and is headquartered in Or Akiva, Israel.

NeatStitch Ltd. develops and manufactures medical devices. It offers NeatClose, a patented Nitinol based automatic suturing product primarily targeting the Laparoscopic Port Closure Market. The firm’s product is FDA approved and employs a simple-intuitive blunt end design therefore avoiding exposed needles and improving the safety and speed of the closure for each procedure. The company was founded in 2004 by Assaf Dekel and is headquartered in Or Akiva, Israel.

QuLab Medical Ltd. engages in the development of technology for diabetes prevention, early diagnosis, and management. The company was founded in 2016 and is headquartered in Herzliya, Israel.